- Home
- ITRG vs ALEC Comparison
ITRG vs ALEC Comparison
Compare ITRG & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- ALEC
- Stock Information
- Founded
- ITRG 1997
- ALEC 2013
- Country
- ITRG Canada
- ALEC United States
- Employees
- ITRG N/A
- ALEC N/A
- Industry
- ITRG Precious Metals
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ITRG Basic Materials
- ALEC Health Care
- Exchange
- ITRG Nasdaq
- ALEC Nasdaq
- Market Cap
- ITRG 227.8M
- ALEC 101.1M
- IPO Year
- ITRG N/A
- ALEC 2019
- Fundamental
- Price
- ITRG $1.73
- ALEC $1.04
- Analyst Decision
- ITRG Strong Buy
- ALEC Buy
- Analyst Count
- ITRG 1
- ALEC 7
- Target Price
- ITRG $2.75
- ALEC $4.10
- AVG Volume (30 Days)
- ITRG 1.5M
- ALEC 903.5K
- Earning Date
- ITRG 05-14-2025
- ALEC 05-16-2025
- Dividend Yield
- ITRG N/A
- ALEC N/A
- EPS Growth
- ITRG N/A
- ALEC N/A
- EPS
- ITRG N/A
- ALEC N/A
- Revenue
- ITRG $30,350,000.00
- ALEC $100,558,000.00
- Revenue This Year
- ITRG $746.16
- ALEC N/A
- Revenue Next Year
- ITRG N/A
- ALEC $376.51
- P/E Ratio
- ITRG N/A
- ALEC N/A
- Revenue Growth
- ITRG N/A
- ALEC 3.60
- 52 Week Low
- ITRG $0.73
- ALEC $0.87
- 52 Week High
- ITRG $1.88
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- ITRG 56.23
- ALEC 43.22
- Support Level
- ITRG $1.61
- ALEC $1.07
- Resistance Level
- ITRG $1.95
- ALEC $1.34
- Average True Range (ATR)
- ITRG 0.12
- ALEC 0.10
- MACD
- ITRG -0.01
- ALEC 0.01
- Stochastic Oscillator
- ITRG 34.33
- ALEC 31.19
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.